BIKTARVY

BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE · Gilead Sciences, Inc.

Drug timelines are a Plus or Pro feature.

50 regulatory and trial events tracked for BIKTARVY, covering 2018-02-07 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed [Phase 2, Phase 3]

See pricing